Evidence map›Paper›PMID 37605108›Full record

ArticleBMC bioinformatics2023

BioLegato: a programmable, object-oriented graphic user interface.

Graham Alvare, Abiel Roche-Lima, Brian Fristensky

Abstract read
In one paragraph

Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Graham AlvareAccess Norwest Co-op Community Health, Winnipeg, Canada.
Abiel Roche-LimaRCMI Program, Medical Science Campus, University of Puerto Rico, San Juan, Puerto Rico, USA.
Brian FristenskyDepartment of Plant Science, University of Manitoba, Winnipeg, Canada. brian.fristensky@umanitoba.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBiologists are faced with an ever-changing array of complex software tools with steep learning curves, often run on High Performance Computing platforms. To resolve the tradeoff between analytical sophistication and usability, we have designed BioLegato, a programmable graphical user interface (GUI) for running external programs.

resultsBioLegato can run any program or pipeline that can be launched as a command. BioLegato reads specifications for each tool from files written in PCD, a simple language for specifying GUI components that set parameters for calling external programs. Thus, adding new tools to BioLegato can be done without changing the BioLegato Java code itself. The process is as simple as copying an existing PCD file and modifying it for the new program, which is more like filling in a form than writing code. PCD thus facilitates rapid development of new applications using existing programs as building blocks, and getting them to work together seamlessly.

conclusionBioLegato applies Object-Oriented concepts to the user experience by organizing applications based on discrete data types and the methods relevant to that data. PCD makes it easier for BioLegato applications to evolve with the succession of analytical tools for bioinformatics. BioLegato is applicable not only in biology, but in almost any field in which disparate software tools need to work as an integrated system.

Indexed as

Computational BiologyLanguageSoftwareWritingData pipeliningGenomicsGraphic user interfaceSequencingTranscriptomicsUser experience

Identifiers

PMID37605108
PMCPMC10441721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.